Financial Statements 13 Trade and other receivables 2014 2013 Amounts falling due within one year m m Trade receivables 1,069 1,173 Less: Provision for impairment of receivables 33 44 Trade receivables net 1,036 1,129 Other receivables 233 126 Prepayments and accrued income 38 51 1,307 1,306 Trade receivables Trade receivables consist of a broad cross-section of our international customer base for whom there is no significant history of default.
The credit risk of customers is assessed at a subsidiary and Group level, taking into account their financial positions, past experiences and other relevant factors.
Individual customer credit limits are imposed based on these factors.
As at 31 December 2014, trade receivables of 72m 2013: 77m were past due but not impaired.
The ageing analysis of trade receivables past due but not impaired is as follows: 2014 2013 Amounts past due but not impaired m m Up to 3 months 72 77 As at 31 December 2014, trade receivables of 70m 2013: 71m were considered to be impaired.
The amount of provision at 31 December 2014 was 33m 2013: 44m.
It was assessed that a portion of the receivables is expected to be recovered due to the nature and historical collection of trade receivables.
The ageing analysis of these receivables is as follows: 2014 2013 Ageing analysis of amounts impaired m m Up to 3 months 50 33 Over 3 months 20 38 70 71 The movement in the provision for impaired receivables consists of increases for additional provisions offset by receivables written off and unused provision released back to the income statement.
The gross movements in the provision are considered to be insignificant.
other receivables Other Receivables include recoverable sales tax of 121m 2013: 62m.
This contains 6m 2013: nil of impaired assets all aged over 3 months from a broad range of countries within the Group.
The carrying amounts of the Groups trade and other receivables are denominated in the following currencies: 2014 2013 m m Sterling 167 101 Euro 261 282 US dollar 236 283 Brazil Real 95 107 Other currencies 548 533 1,307 1,306 The maximum exposure to credit risk at the year end is the carrying value of each class of receivable mentioned above.
The Group does not hold any collateral as security.
other non-current receivables Non-current other receivables at 31 December 2014 were 240m 2013: 249m.
This includes a prepayment of 194m for an option to acquire legal title to intellectual property relating to our 3 year collaboration with Bristol-Myers Squibb entered into in May 2013 and exercisable at the end of the collaboration period in 2016 subject to certain payments.
This is in addition to the 311m upfront payment.
The remaining balance relates to other non-current prepayments and receivables due after one year.
RB Annual Report and Financial Statements 2014 95
